Recombinant human erythropoietin in the treatment of acute ischemic stroke

Ehrenreich, Hannelore; Weissenborn, Karin; Prange, Hilmar; Schneider, Dietmar; Weimar, Christian; Wartenberg, Katja; Schellinger, Peter D.; Bohn, Matthias; Becker, Harald; Wegrzyn, Martin; Jähnig, Peter; Herrmann, Manfred; Knauth, Michael; Bähr, Mathias; Heide, Wolfgang; Wagner, Armin; Schwab, Stefan; Reichmann, Heinz; Schwendemann, Günther; Dengler, Reinhard; Kastrup, Andreas; Bartels, Claudia

doi:10.1161/STROKEEAHA.109.564872

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Recombinant human erythropoietin in the treatment of acute ischemic stroke

MPS-Authors

/persons/resource/persons182138

Ehrenreich, Hannelore
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182477

Wegrzyn, Martin
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182082

Bartels, Claudia
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., et al. (2009). Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke, 40(12), E647-E656. doi:10.1161/STROKEEAHA.109.564872.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-2DAC-4

Abstract

There is no abstract available